Literature DB >> 17339255

Screening for coeliac disease in patients fulfilling the Rome II criteria for irritable bowel syndrome in a secondary care hospital in The Netherlands: a prospective observational study.

Egbert-Jan van der Wouden, G Frits Nelis, Juda Vecht.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17339255      PMCID： PMC1856831          DOI： 10.1136/gut.2006.112052

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 2.  Coeliac disease in Europe.

Authors:  R McLoughlin; S S Sebastian; A Qasim; D McNamara; H J O'Connor; M Buckley; C O'Morain
Journal:  Aliment Pharmacol Ther       Date:  2003-11       Impact factor: 8.171

Review 3.  The global village of celiac disease.

Authors:  S Accomando; F Cataldo
Journal:  Dig Liver Dis       Date:  2004-07       Impact factor: 4.088

4.  Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care.

Authors:  D S Sanders; M J Carter; D P Hurlstone; A Pearce; A M Ward; M E McAlindon; A J Lobo
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

5.  The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

Authors:  A P S Hungin; P J Whorwell; J Tack; F Mearin
Journal:  Aliment Pharmacol Ther       Date:  2003-03-01       Impact factor: 8.171

6.  Celiac disease and irritable bowel-type symptoms.

Authors:  Clare O'Leary; Peter Wieneke; Sarah Buckley; Paud O'Regan; Comeilius C Cronin; Eamonn M M Quigley; Fergus Shanahan
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

7.  Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis.

Authors:  Brennan M R Spiegel; Vincent P DeRosa; Ian M Gralnek; Victor Wang; Gareth S Dulai
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

8.  Coeliac disease in The Netherlands.

Authors:  J J Schweizer; B M E von Blomberg; H B Bueno-de Mesquita; M L Mearin
Journal:  Scand J Gastroenterol       Date:  2004-04       Impact factor: 2.423

9.  Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study.

Authors:  G Richard Locke; Joseph A Murray; Alan R Zinsmeister; L Joseph Melton; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2004-04       Impact factor: 7.616

10.  Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis.

Authors:  S M Mein; U Ladabaum
Journal:  Aliment Pharmacol Ther       Date:  2004-06-01       Impact factor: 8.171
  10 in total
  6 in total

Review 1.  Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.

Authors:  Andrew J Irvine; William D Chey; Alexander C Ford
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

2.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

3.  Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Gastroenterol Res Pract       Date:  2014-06-16       Impact factor: 2.260

4.  Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  Mol Med Rep       Date:  2019-05-23       Impact factor: 2.952

Review 5.  The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja; Trygve Hausken
Journal:  Nutr J       Date:  2015-09-07       Impact factor: 3.271

Review 6.  Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan G Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2014-06-17       Impact factor: 4.101
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.